OncoPatch Investor Deep Dive

OncoPatch is a medical device and services company dedicated to advancing non-invasive treatment for skin cancer through Y-90 patch brachytherapy. Designed for use in outpatient dermatology settings, the self-shielded patch delivers targeted radiation to the first few millimeters of skin, providing highly focal treatment while sparing deeper tissues.

The RVC Deep Dive is a 90 minute virtual meeting held between company executive leadership, RVC Investors, and RVC staff. The purpose of this meeting is to cover all major due diligence questions such as business strategy, team, product, competition, IP, market, traction, key risks, and exit strategy. 

The structure of the meeting is as follows:

• Company Pitch (15 minutes)
• Guided Q&A w/ Investors (45 minutes)
• Investor Only Discussion (30 minutes)

To attend, you must be an accredited investor (net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 together with his or her spouse if married] and have the expectation to make the same amount this year). We do not require a minimum investment.